Immunic hosts RMS R&D Day webinar, outlines vidofludimus plans
Immunic said it is hosting a relapsing multiple sclerosis R&D Day webinar and presented vidofludimus calcium development plans in an original SEC filing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.